Protocol for screening potential targets for the treatment of hepatocellular carcinoma based on H22 tumor-bearing mouse model.

Fuente: PubMed
Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Gao, Xiaoxiang, Qiu, Yinghui, Liao, Wei, Zhao, Chao
Format: Artículo científico
Sprache:en
Veröffentlicht: STAR protocols 2024
Schlagworte:
Online-Zugang:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
_version_ 1868266290212241409
author Gao, Xiaoxiang
Qiu, Yinghui
Liao, Wei
Zhao, Chao
author_facet Gao, Xiaoxiang
Qiu, Yinghui
Liao, Wei
Zhao, Chao
Gao, Xiaoxiang
Qiu, Yinghui
Liao, Wei
Zhao, Chao
collection PubMed - marine biology
contents Protocol for screening potential targets for the treatment of hepatocellular carcinoma based on H22 tumor-bearing mouse model. Gao, Xiaoxiang Qiu, Yinghui Liao, Wei Zhao, Chao Animals Carcinoma, Hepatocellular Mice Liver Neoplasms MicroRNAs Fluorouracil Disease Models, Animal Cell Line, Tumor Regulating cancer-related microRNAs (miRNAs) may become a new generation of therapeutic modalities for cancer treatment. Here, we describe a protocol based on hepatoma-22 (H22) tumor-bearing mice to screen potential targets for treating hepatocellular carcinoma (HCC). We detail the construction of H22 tumor-bearing mice and treatment with two natural compounds, Ulva lactuca L. polysaccharide (ULP) and 5-fluorouracil (5FU). We further describe the isolation of the tumor tissues for miRNA sequencing and the discovery and validation of potential miRNA gene targets against HCC. For complete details on the use and execution of this protocol, please refer to Qiu et al..
format Artículo científico
id pubmed_39423126
institution PubMed
language en
publishDate 2024
publisher STAR protocols
record_format pubmed
spellingShingle Protocol for screening potential targets for the treatment of hepatocellular carcinoma based on H22 tumor-bearing mouse model.
Gao, Xiaoxiang
Qiu, Yinghui
Liao, Wei
Zhao, Chao
Animals
Carcinoma, Hepatocellular
Mice
Liver Neoplasms
MicroRNAs
Fluorouracil
Disease Models, Animal
Cell Line, Tumor
Protocol for screening potential targets for the treatment of hepatocellular carcinoma based on H22 tumor-bearing mouse model. Gao, Xiaoxiang Qiu, Yinghui Liao, Wei Zhao, Chao Animals Carcinoma, Hepatocellular Mice Liver Neoplasms MicroRNAs Fluorouracil Disease Models, Animal Cell Line, Tumor Regulating cancer-related microRNAs (miRNAs) may become a new generation of therapeutic modalities for cancer treatment. Here, we describe a protocol based on hepatoma-22 (H22) tumor-bearing mice to screen potential targets for treating hepatocellular carcinoma (HCC). We detail the construction of H22 tumor-bearing mice and treatment with two natural compounds, Ulva lactuca L. polysaccharide (ULP) and 5-fluorouracil (5FU). We further describe the isolation of the tumor tissues for miRNA sequencing and the discovery and validation of potential miRNA gene targets against HCC. For complete details on the use and execution of this protocol, please refer to Qiu et al..
title Protocol for screening potential targets for the treatment of hepatocellular carcinoma based on H22 tumor-bearing mouse model.
topic Animals
Carcinoma, Hepatocellular
Mice
Liver Neoplasms
MicroRNAs
Fluorouracil
Disease Models, Animal
Cell Line, Tumor
url https://pubmed.ncbi.nlm.nih.gov/39423126/